600
Views
2
CrossRef citations to date
0
Altmetric
Invited Reviews

Sympathetic Ophthalmia - An Overview

, MD, FRCS Ed, FRCOphthORCID Icon, , MDORCID Icon, , MD, , MD, , MD, , MD & , MD, PhD, MPH show all
Pages 793-809 | Received 15 Apr 2021, Accepted 20 Mar 2022, Published online: 17 May 2022

References

  • Albert DM, Diaz-Rohena R. A historical review of sympathetic ophthalmia and its epidemiology. Surv Ophthalmol. 1989;34(1):1–14. doi:10.1016/0039-6257(89)90125-2.
  • Mackenzie W. A Practical Treatise on the Diseases of the Eye. London: Longmans; 1840.
  • Fuchs E. Uber sympathisietende Entzundung (nebst Bemerkungen uber serose traumatische Iritis). Graefe’s Arch Clin Exp Ophthalmol. 1905;61:365–456. doi:10.1007/BF01969717.
  • Kaden R. [Historic notices of Louis Braille and the development of dot-writing (author’s transl)]. Klin Monatsbl Augenheilkd. 1977;170:154–158.
  • Jimenez J, Olea J, Torres J, Alonso I, Harder D, Fischer K. Biography of Louis Braille and invention of the Braille Alphabet. Surv Ophthalmol. 2009;54(1):142–149. doi:10.1016/j.survophthal.2008.10.006.
  • Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol. 2000;84(3):259–263. doi:10.1136/bjo.84.3.259.
  • Court JH, Lu LM, Wang N, McGhee CN. Visual and ocular morbidity in severe open globe injuries presenting to a regional eye centre in New Zealand. Clin Exp Ophthalmol. 2019;47(4):469–477. doi:10.1111/ceo.13439.
  • Kumar K, Mathai A, Murthy SI, et al. Sympathetic ophthalmia in pediatric age group: clinical features and challenges in management in a tertiary center in southern India. Ocul Immunol Inflamm. 2014;22(5):367–372. doi:10.3109/09273948.2013.841958.
  • Marak G. Recent advances in sympathetic ophthalmia. Surv Ophthalmol. 1979;24(3):141–156. doi:10.1016/0039-6257(79)90018-3.
  • Rua D, Pohlmann D, Pleyer U. Sympathetic ophthalmia - a contribution to immunology, clinic and current imaging. Klin Monatsbl Augenheilkd. 2020;237(9):1060–1069. doi:10.1055/a-1245-4373.
  • Makley TA, Azar A. Sympathetic ophthalmia. A long-term follow-up. Arch Ophthalmol. 1978;96(2):257–262. doi:10.1001/archopht.1978.03910050125004.
  • Lubin JR, Albert DM, Weinstein M. Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913–1978). Ophthalmology. 1980;87(2):109–121. doi:10.1016/S0161-6420(80)35270-6.
  • Tan XL, Seen S, Majumder PD, et al. Analysis of 130 cases of sympathetic ophthalmia – a retrospective multicenter case series. Ocul Immunol Inflamm. 2019;27(8):1259–1266. doi:10.1080/09273948.2018.1517894.
  • Yang P, Liu S, Zhong Z, Du L, Ye Z. Comparison of clinical features and visual outcome between sympathetic ophthalmia and Vogt-Koyanagi-Harada disease in Chinese patients. Ophthalmology. 2019;126(9):1297–1305. doi:10.1016/j.ophtha.2019.03.049.
  • Galor A, Davis JL, Flynn HW, et al. Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. AJOPHT. 2009;148(5):704–710.e2. doi:10.1016/j.ajo.2009.05.033.
  • Reynard M, Riffenburgh RS, Maes EF. Effect of corticosteroid treatment and enucleation on the visual prognosis of sympathetic ophthalmia. Am J Ophthalmol. 1983;96(3):290–294. doi:10.1016/S0002-9394(14)77816-X.
  • Jennings T, Tessler HH. Twenty cases of sympathetic ophthalmia. Br J Ophthalmol. 1989;73(2):140–145. doi:10.1136/bjo.73.2.140.
  • Hakin KN, Pearson RV, Lightman SL. Sympathetic ophthalmia: visual results with modern immunosuppressive therapy. Eye. 1992;6(5):453–455. doi:10.1038/eye.1992.95.
  • Chan -C-C, Roberge FG, Whitcup SM, Nussenblatt RB. 32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md., from 1982 to 1992. Arch Ophthalmol. 1995;113(5):597–600. doi:10.1001/archopht.1995.01100050065032.
  • Rathinam SR, Rao NA. Sympathetic ophthalmia following postoperative bacterial endophthalmitis: a clinicopathologic study. Am J Ophthalmol. 2006;141(3):498–507. doi:10.1016/j.ajo.2005.10.047.
  • Dh-w S, Chee S-P. Sympathetic ophthalmia in Singapore: new trends in an old disease. Graefe’s Arch Clin Exp Ophthalmol. 2006;244(2):243–247. doi:10.1007/s00417-005-0009-4.
  • Gupta V, Gupta A, Dogra MR. Posterior sympathetic ophthalmia: a single centre long-term study of 40 patients from North India. Eye. 2008;22(12):1459–1464. doi:10.1038/sj.eye.6702927.
  • Mahajan VB, Gehrs KM, Goldstein DA, Fischer DH, Lopez JS, Folk JC. Management of sympathetic ophthalmia with the fluocinolone acetonide implant. Ophthalmology. 2009;116(3):552–557.e1. doi:10.1016/j.ophtha.2008.10.024.
  • Patel SS, Dodds EM, Echandi LV, et al. Long-term, drug-free remission of sympathetic ophthalmia with high-dose, short-term chlorambucil therapy. Ophthalmology. 2014;121(2):596–602. doi:10.1016/j.ophtha.2013.09.009.
  • Aziz HA, Flynn HW, Young RC, Davis JL, Dubovy SR. Sympathetic ophthalmia: clinicopathologic correlation in a consecutive case series. Retina. 2015;35(8):1696–1703. doi:10.1097/IAE.0000000000000506.
  • Rishi E, Rishi P, Appukuttan B, Walinjkar J, Biswas J, Sharma T. Sympathetic ophthalmia after vitreoretinal surgeries: incidence, clinical presentations and outcomes of a rare disease. Indian J Ophthalmol. 2015;63(9):692–699. doi:10.4103/0301-4738.170980.
  • Guzman-Salas PJ, Serna-Ojeda JC, Guinto-Arcos EB, Pedroza-Seres M. Characteristics of sympathetic ophthalmia in a single international center. Open Ophthalmol J. 2016;10:154–159. doi:10.2174/1874364101610010154.
  • Payal AR, Foster CS. Long-term drug-free remission and visual outcomes in sympathetic ophthalmia. Ocul Immunol Inflamm. 2017;25(2):190–195. doi:10.3109/09273948.2015.1092557.
  • Chawla R, Glasg F, Kapoor M, Mehta A, Tripathy K, Venkatesh P. Sympathetic ophthalmia: experience from a tertiary care center in Northern India. J Ophthalmic Vis Res. 2018;13(4):439–446. doi:10.4103/jovr.jovr.
  • Majumder PD, Anthony E, George AE, Ganesh SK, Biswas J. Postsurgical sympathetic ophthalmia: retrospective analysis of a rare entity. Int Ophthalmol. 2018;38(6):2487–2493. doi:10.1007/s10792-017-0759-0.
  • Tyagi M, Agarwal K, Pappuru RRR, et al. Sympathetic ophthalmia after vitreoretinal surgeries: incidence, clinical presentations and outcomes of a rare disease. Semin Ophthalmol. 2019;34(3):157–162. doi:10.1080/08820538.2019.1610464.
  • Yang J, Li Y, Xie R, Li X, Zhang X. Sympathetic ophthalmia: report of a case series and comprehensive review of the literature. Eur J Ophthalmol. 2020;Epub ahead of print:1–11. doi:10.1177/1120672120977359.
  • Cunningham ET, Kilmartin D, Agarwal M, Zierhut M. Sympathetic ophthalmia. Ocul Immunol Inflamm. 2017;25(2):149–151. doi:10.1080/09273948.2017.1305727.
  • Brouzas D, Koutsandrea C, Moschos M, Papadimitriou S, Ladas I, Apostolopoulos M. Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin ®) for AMD followed by contralateral sympathetic ophthalmia. Clin Ophthalmol. 2009;3:457–459. doi:10.2147/opth.s4641.
  • Garcia-Arumi J, Gil MM, Palau MM, Garcia AS. Sympathetic ophthalmia after surgical resection of iridociliary melanoma. A case report. Graefe’s Arch Clin Exp Ophthalmol. 2006;244(10):1353–1356. doi:10.1007/s00417-006-0299-1.
  • Fries PD, Char DH, Crawford JB, Waterhouse W. Sympathetic ophthalmia complicating helium ion irradiation of a choroidal melanoma. Arch Ophthalmol. 1987;105(11):1561–1564. doi:10.1001/archopht.1987.01060110107042.
  • Brour J, Desjardins L, Lehoang P, et al. Sympathetic ophthalmia after proton beam irradiation for choroidal melanoma. Ocul Immunol Inflamm. 2012;20(4):273–276. doi:10.3109/09273948.2012.689072.
  • Ahmad N, Soong T, Salvi S, Rudle P, Rennie I. Sympathetic ophthalmia after ruthenium plaque brachytherapy. Br J Ophthalmol. 2007;91(3):399–401. doi:10.1136/bjo.2006.102384.
  • Biswas J, Fogla R. Sympathetic ophthalmia following cyclocryotherapy with histopathologic correlation. Ophthalmic Surg Lasers. 1996;27(12):1035–1038. doi:10.3928/1542-8877-19961201-11.
  • Harrison T. Sympathetic ophthalmia after cyclocryotherapy of neovascular glaucoma without ocular penetration. Ophthalmic Surg. 1993;24:44–46.
  • Albahlal A, Al Dhibi H, Al Shahwan S, Khandekar R, Edward DP. Sympathetic ophthalmia following diode laser cyclophotocoagulation. Br J Ophthalmol. 2014;98(8):1101–1106. doi:10.1136/bjophthalmol-2013-304257.
  • Aujla JS, Lee GA, Vincent SJ, Thomas R. Incidence of hypotony and sympathetic ophthalmia following trans-scleral cyclophotocoagulation for glaucoma and a report of risk factors. Clin Exp Ophthalmol. 2013;41(8):761–772. doi:10.1111/ceo.12088.
  • Bawankar P, Das D, Tayab S, et al. Cyclophotocoagulation-induced sympathetic ophthalmia in a Coats’ disease patient supported by histopathology and immunohistochemistry. Indian J Ophthalmol. 2017;65(8):744–746. doi:10.4103/ijo.IJO.
  • Roberts MA, Rajkumar V, Morgan G, Laws D. Sympathetic ophthalmia secondary to cyclodiode laser in a 10-year-old boy. J AAPOS. 2009;13(3):299–300. doi:10.1016/j.jaapos.2008.12.135.
  • Pastor SA, Iwach A, Nozik RA, Hetherington J, Fellman R. Presumed sympathetic ophthalmia following Nd: YAG Transscleral Cyclophotocoagulation. J Glaucoma. 1993;2(1):30–31. doi:10.1097/00061198-199300210-00009.
  • Griepentrog GJ, Lucarelli MJ, Albert DM, Nork MT. Sympathetic ophthalmia following evisceration: a rare case. Ophthalmic Plast Reconstr Surg. 2005;21(4):316–318. doi:10.1097/01.iop.0000170404.23769.00.
  • Leal I, Cordeiro Sousa D, Loureiro C, Fonseca A. Sympathetic ophthalmia related to conjunctival invasive squamous-cell carcinoma. Indian J Ophthalmol. 2017;65(8):741–743. doi:10.4103/ijo.IJO.
  • Kilmartin DJ, Dick AD, Forrester JV. Sympathetic ophthalmia risk following vitrectomy: should we counsel patients? Br J Ophthalmol. 2000;84(5):448–449. doi:10.1136/bjo.84.5.448.
  • Castiblanco CP, Adelman RA. Sympathetic ophthalmia. Graefe’s Arch Clin Exp Ophthalmol. 2009;247:289–302. doi:10.1007/s00417-008-0939-8.
  • Gass JDM. Sympathetic ophthalmia following vitrectomy. Am J Ophthalmol. 1982;93(5):552–558. doi:10.1016/S0002-9394(14)77368-4.
  • Cha D, Woo S, Ahn J, Park K. A case of sympathetic ophthalmia presenting with extraocular symptoms and conjunctival pigmentation after repeated 23-gauge vitrectomy. Ocul Immunol Inflamm. 2010;18(4):265–267. doi:10.3109/09273941003778793.
  • Parvaresh MM, Falavarjani KG. Presumed sympathetic ophthalmia after scleral buckling surgery. Retin Cases Br Rep. 2013;7(4):331–333. doi:10.1097/ICB.0b013e318290d70b.
  • Pollack AL, McDonald HR, Ai E, et al. Sympathetic ophthalmia associated with pars plana vitrectomy without antecedent penetrating trauma. Retina. 2001;21(2):146–154. doi:10.1097/00006982-200104000-00008.
  • Spirn MJ. Comparison of 25, 23 and 20-gauge vitrectomy. Curr Opin Ophthalmol. 2009;20(9):195–199. doi:10.1097/ICU.0b013e328329eaea.
  • de Kozak Y, Sakai J, Thillaye B, Faure J. S antigen-induced experimental autoimmune uveo-retinitis in rats. Curr Eye Res. 1981;1(6):327–337. doi:10.3109/02713688108998359.
  • Chu XK, Chan C. Sympathetic ophthalmia: to the twenty-first century and beyond. J Ophthalmic Inflamm Infect. 2013;3(1):49. doi:10.1186/1869-5760-3-49.
  • Chan C, Hikita N, Dastgheib K, Whitcup SM, Gery I, Nussenblatt RB. Experimental melanin-protein– induced Uveitis in the Lewis rat. Ophthalmology. 1994;101(7):1275–1280. doi:10.1016/S0161-6420(94)31199-7.
  • Patil AJ, Edward DP, Wong M, Ravichandran P, Goldstein DA. The role of perivascular melanophage infiltrates in the conjunctiva in sympathetic ophthalmia. Ocul Immunol Inflamm. 2011;19(3):186–191. doi:10.3109/09273948.2010.538122.
  • Viswanathan D, Haider AS, Dunlop A, McKeag D. Sympathetic ophthalmia associated with untreated choroidal melanoma. Can J Ophthalmol. 2018;53(5):e173–e176. doi:10.1016/j.jcjo.2017.11.013.
  • Shen J, Fang W, Jin X, Yao Y, Li Y. Sympathetic ophthalmia caused by a severe ocular chemical burn: a case report and literature review. Int J Clin Exp Med. 2015;8:2974–2978.
  • Rahman Z, Ali S, Majumder PD. Sympathetic ophthalmia following accidental burn with hot water involving the other eye. Ocul Immunol Inflamm. 2018;26(8):1225–1227. doi:10.1080/09273948.2017.1340960.
  • Rao NA, Wong VG. Aetiology of sympathetic ophthalmitis. Trans Ophthalmol Soc UK. 1981;101:357–360.
  • Guerriero S, Montepara A, Ciracı L, Monno R, Cinquepalmi V, Vetrugno M. A case of sympathetic ophthalmia after a severe acanthamoeba keratitis. Eye Contact Lens. 2011;37(6):374–376. doi:10.1097/ICL.0b013e3182128e93.
  • Buller A, Doris J, Bonshek R, Brahma A, Jones N. Sympathetic ophthalmia following severe fungal keratitis. Eye (Lond). 2006;20(11):1306–1307. doi:10.1038/sj.eye.6702156.
  • Shindo Y, Ohno S, Usui M, et al. Immunogenetic study of sympathetic ophthalmia. Tissue Antigens. 1997;49(2):111–115. doi:10.1111/j.1399-0039.1997.tb02723.x.
  • Davis JL, Mittal KK, Freidlin V, Mellow SR, Optican RNDC, Palestine MASAG. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Ophthalmology. 1990;97(9):1137–1142. doi:10.1016/S0161-6420(90)32446-6.
  • Kilmartin DJ, Wilson D, Liversidge J, et al. Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol. 2001;85(3):281–286. doi:10.1136/bjo.85.3.281.
  • Rao NA. Sympathetic ophthalmia. In: Ryan SJ, ed. Retina. Vol. 2. 3rd ed. New York: Mosby; 2001:1756–1761.
  • Furusato E, Shen D, Cao X, et al. Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: a pilot study. Histol Histopathol. 2011;26(9):1145–1151. doi:10.14670/HH-26.1145.
  • de la Fuente MA, Alejandre N, Ferrer P, Fernandez G, Sarasa JL, Sanchez O. Sympathetic ophthalmia in HIV infection. A clinicopathological case report. J Ophthalmic Inflamm Infect. 2012;2(3):161–164. doi:10.1007/s12348-012-0065-y.
  • Chan -C-C, Nussenblatt RB, Fujikawa LS, et al. Sympathetic ophthalmia. Immunopathological findings. Ophthalmology. 1986;93(5):690–695. doi:10.1016/S0161-6420(86)33694-7.
  • Shah DN, Piacentini MA, Burnier MN, Mclean IW, Nussenblatt B, Chan -C-C. Inflammatory cellular kinetics in sympathetic ophthalmia a study of 29 traumatized (exciting) eyes. Ocul Immunol Inflamm. 1993;1(3):255–262. doi:10.3109/09273949309085026.
  • Abu El-Asrar AM, Struyf S, Van den Broeck C, et al. Expression of chemokines and gelatinase B in sympathetic ophthalmia. Eye. 2007;21(5):649–657. doi:10.1038/sj.eye.6702342.
  • Kaneko Y, Rao NA. Mitochondrial oxidative stress initiates visual loss in sympathetic ophthalmia. Jpn J Ophthalmol. 2012;56(3):191–197. doi:10.1007/s10384-012-0132-9.
  • Inomata H, Rao NA. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001;131(5):607–614. doi:10.1016/s0002-9394(00)00851-5.
  • Zaharia M, Lamarche J, Laurin M. Sympathetic uveitis 66 years after injury. Can J Ophthalmol. 1984;19:240–243.
  • Arevalo JF, Garcia RA, Al-dhibi HA, Sanchez JG, Suarez-tata L. Update on sympathetic ophthalmia. Middle East Afr J Ophthalmol. 2012;19(1):13–21. doi:10.4103/0974-9233.92111.
  • Jang M, Lee HJ, Jeong JH, Kim JY. Rare case of sympathetic ophthalmia with severe annular choroidal detachment. Can J Ophthalmol. 2019;54(1):e6–e10. doi:10.1016/j.jcjo.2018.04.009.
  • Wang RC, Zamir E, Dugel PU, et al. Progressive subretinal fibrosis and blindness associated with multifocal granulomatous chorioretinitis: a variant of sympathetic ophthalmia. Ophthalmology. 2002;109(8):1527–1531. doi:10.1016/s0161-6420(02)01108-9.
  • Gass JD, Margo CE, Levy MH. Progressive subretinal fibrosis and blindness in patients with multifocal granulomatous chorioretinitis. Am J Ophthalmol. 1996;122(1):76–85. doi:10.1016/S0002-9394(14)71966-X.
  • Lim W-K, Chee S-P, Sng I, Nussenblatt RB, Chan -C-C. Immunopathology of progressive subretinal fibrosis: a variant of sympathetic ophthalmia. Am J Ophthalmol. 2000;138(3):475–477. doi:10.1016/j.ajo.2004.04.013.
  • Bansal R, Bansal P, Gupta A, et al. Diagnostic challenges in inflammatory choroidal neovascular membranes. Ocul Immunol Inflamm. 2017;25(4):554–562. doi:10.3109/09273948.2016.1160128.
  • Chaithanyaa N, Devireddy SK, Kumar RVK, Gali RS, Aneja V. Sympathetic ophthalmia: a review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113(2):172–176. doi:10.1016/j.tripleo.2011.01.036.
  • Goudot M, Groh M, Salah S, Monnet D, Blanche P, Brézin AP. Lymphocytic meningitis in patients with sympathetic ophthalmia. Ocul Immunol Inflamm. 2017;25(2):196–201. doi:10.1080/09273948.2017.1291841.
  • Venkatesh R, Agarwal M, Ramesh VJ, Singh S, Kantha M, Biswas J. Sympathetic ophthalmia with sensorineural deafness - report of a case. J Ophthalmic Inflamm Infect. 2013;3(1):65. doi:10.1186/1869-5760-3-65.
  • Kawashima Y, Noguchi Y, Takase H, Takahashi M, Horie S. Bilateral hearing impairment as the initial symptom of sympathetic ophthalmia. Am J Otolaryngol - Head Neck Med Surg. 2015;36(4):606–610. doi:10.1016/j.amjoto.2015.02.007.
  • Nirankari MS, Khanna KK, Chawla GD, Mathur RP. Sympathetic ophthalmitis with total deafness (a case report). J All India Ophthalmol Soc. 1970;18:29–32.
  • Comer M, Taylor C, Chen S, Martin K, Jordan K, Meyer P. Sympathetic ophthalmia associated with high frequency deafness. Br J Ophthalmol. 2001;85(4):496. doi:10.1136/bjo.85.4.496.
  • Kinast RM, Solomon SD, Cubillan LD, Hovakimyan A, Acharya N, Cunningham ETJ. Prevalence and causes of clinically detectable uveitic serous retinal detachment. Eur J Ophthalmol. 2021;Feb 2:1120672121991391. doi:10.1177/1120672121991391.
  • Shah DN, Al-Moujahed A, Newcomb CW, et al. Exudative retinal detachment in ocular inflammatory diseases: risk and predictive factors. Am J Ophthalmol. 2020;218:279–287. doi:10.1016/j.ajo.2020.06.019.
  • Mahajan S, Invernizzi A, Agrawal R, Biswas J, Rao NA, Gupta V. Multimodal imaging in sympathetic ophthalmia. Ocul Immunol Inflamm. 2017;25(2):152–159. doi:10.1080/09273948.2016.1255339.
  • Pichi F, Invernizzi A, Tucker WR, Munk MR. Optical coherence tomography diagnostic signs in posterior uveitis. Prog Retin Eye Res. 2020;75:100797. doi:10.1016/j.preteyeres.2019.100797.
  • Cicinelli MV, Giuffré C, Marchese A, et al. The bacillary detachment in posterior segment ocular diseases. Ophthalmol Retin. 2020;4(4):454–456. doi:10.1016/j.oret.2019.12.003.
  • Castiblanco C, Adelman RA. Imaging for sympathetic ophthalmia: impact on the diagnosis and management. Int Ophthalmol Clin. 2012;52(4):173–181. doi:10.1097/IIO.0b013e318265d5c7.
  • Abdelmaksoud A, Khoo NT, Sears K, Winder S. Novel optical coherence tomography findings of a case of sympathetic ophthalmia after 23-gauge vitrectomy. Retin Cases Br Rep. 2019;Epub ahead:1–5. doi:10.1097/ICB.0000000000000847.
  • Rogaczewska M, Iwanik K, Stopa M. Early presentation of sympathetic ophthalmia in optical coherence tomography studies: a case report. Ind J Chest Dis Allied Sci. 2020;68(9):2019–2023. doi:10.4103/ijo.IJO.
  • Behdad B, Rahmani S, Montahaei T, Soheilian R, Soheilian M. Enhanced depth imaging OCT (EDI-OCT) findings in acute phase of sympathetic ophthalmia. Int Ophthalmol. 2015;35(3):433–439. doi:10.1007/s10792-015-0058-6.
  • Correnti AJ, Read RW, Kimble JA, Morris RE. Imaging of dalen-fuchs nodules in a likely case of sympathetic ophthalmia by fluorescein angiography and OCT. Ophthalmic Surg Lasers Imaging. 2010;Epub ahead:1–3. doi:10.3928/15428877-20100215-56.
  • Agarwal M, Radosavljevic A, Patnaik G, Rishi E, Pichi F. Diagnostic value of optical coherence tomography in the early diagnosis of macular complications in chronic Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2020;1–8. [ Epub ahead of print]. doi:10.1080/09273948.2020.1833225.
  • Fleischman D, Say EAT, Wright JD, Landers MB. Multimodality diagnostic imaging in a case of sympathetic ophthalmia. Ocul Immunol Inflamm. 2012;20(4):300–302. doi:10.3109/09273948.2012.682637.
  • Burkholder BM, Dunn JP. Multiple serous retinal detachments seen on wide-field imaging in a patient with sympathetic ophthalmia. JAMA Ophthalmol. 2014;132(10):1220. doi:10.1001/jamaophthalmol.2014.52.
  • Moshfeghi AA, Harrison SA, Ferrone PJ. Indocyanine green angiography findings in sympathetic ophthalmia. Ophthalmic Surg Lasers Imaging. 2005;36(2):163–166. doi:10.3928/1542-8877-20050301-16.
  • Bernasconi O, Auer C, Zografos L, Herbort CP. Indocyanine green angiographic findings in sympathetic ophthalmia. Graefe’s Arch Clin Exp Ophthalmol. 1998;236(8):635–638. doi:10.1007/s004170050134.
  • Trejo F, Garrell X, Banderas S, Aragón D, Del Carmen Iribarren M, Segura A. Atypical sympathetic ophthalmia presenting with ocular pain associated with posterior scleral involvement. Ocul Immunol Inflamm. 2021;1–4. [ Epub ahead of print]. doi:10.1080/09273948.2021.1891261.
  • Aggarwal K, Agarwal A, Mahajan S, et al. The role of optical coherence tomography angiography in the diagnosis and management of acute Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2018;26(1):142–153. doi:10.1080/09273948.2016.1195001.
  • Brar M, Sharma M, Grewal SPS, Grewal DJ. Treatment response in sympathetic ophthalmia as assessed by widefield OCT angiography. Ophthalmic Surg Lasers Imaging Retin. 2018;49(9):726–730. doi:10.3928/23258160-20180831-13.
  • Winter FC. Sympathetic uveitis; a clinical and pathologic study of the visual result. Am J Ophthalmol. 1955;39(3):340–347. doi:10.1016/0002-9394(55)91277-0.
  • Bellan L. Sympathetic ophthalmia: a case report and review of the need for prophylactic enucleation. Can J Ophthalmol. 1999;34:95–98.
  • Dogra M, Samanta R, Singh P, et al. Surgical intervention in inciting eyes of patients with sympathetic ophthalmia: a case series and review of literature. Ocul Immunol Inflamm. 2019;27(7):1154–1159. doi:10.1080/09273948.2018.1497663.
  • Green WR, Maumenee AE, Sanders TE, Smith ME. Sympathetic uveitis following evisceration. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:625–644.
  • Hebestreit H, Huppertz HI, Sold JE, Dämmrich J. Steroid-pulse therapy may suppress inflammation in severe sympathetic ophthalmia. J Pediatr Ophthalmol Strabismus. 1997;34(2):124–126. doi:10.3928/0191-3913-19970301-16.
  • Sandinha MT, Lake S. Periocular injections of triamcinolone for sympathetic ophthalmia. Clin Exp Ophthalmol. 2010;38(8):819–821. doi:10.1111/j.1442-9071.2010.02350.x.
  • Jonas JB. Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia. Am J Ophthalmol. 2004;137(2):367–368. doi:10.1016/S0002-9394(03)00899-7.
  • Ozdemir H, Karacorlu M, Karacorlu S. Intravitreal triamcinolone acetonide in sympathetic ophthalmia. Graefe’s Arch Clin Exp Ophthalmol. 2005;243(7):734–736. doi:10.1007/s00417-004-1064-y.
  • Almeida DRP, Chin EK, Mears K, Russell SR, Mahajan VB. Spontaneous dislocation of a fluocinolone acetonide implant (Retisert) into the anterior chamber and its successful extraction in sympathetic ophthalmia. Retin Cases Br Rep. 2015;9(2):142–144. doi:10.1097/ICB.0000000000000119.
  • Smith WM, Larson TA, Meleth AD, Krishnadev N, Nussenblatt RB, Sen HN. Corticosteroid-associated osteonecrosis: a rare, but serious, complication in uveitis. Ocul Immunol Inflamm. 2013;21(2):102–107. doi:10.3109/09273948.2012.740129.
  • Ganesh SK, Narayana KM, Biswas J. Peripapillary choroidal atrophy in sympathetic ophthalmia and management with triple-agent immunosuppression. Ocul Immunol Inflamm. 2003;11(1):61–65. doi:10.1076/ocii.11.1.61.15581.
  • Palexas GN, Sussman G, Welsh NH. Ocular and systemic determination of IL-1 beta and tumour necrosis factor in a patient with ocular inflammation. Scand J Immunol Suppl. 1992;11:173–175. doi:10.1111/j.1365-3083.1992.tb01645.x.
  • Soheilian M, Jabbarpourbonyadi M, Soheilian R, Peyman GA. Bilateral uveitis after phakic intraocular lens implantation and management with Adalimumab. J Cart Refract Surg. 2012;38(6):1094–1096. doi:10.1016/j.jcrs.2012.02.026.
  • Kim J-B, Jeroudi A, Angeles-Han ST, Grossniklaus H, Yeh S. Adalimumab for pediatric sympathetic ophthalmia. JAMA Ophthalmol. 2014;132(8):1022–1024. doi:10.1001/jamaophthalmol.2014.426.
  • Hiyama T, Harada Y, Kiuchi Y. Effective treatment of refractory sympathetic ophthalmia with glaucoma using Adalimumab. Am J Ophthalmol Case Reports. 2019;14:1–4. doi:10.1016/j.ajoc.2019.01.009.
  • Hiyama T, Harada Y, Kiuchi Y. Efficacy and safety of adalimumab therapy for the treatment of non-infectious uveitis: efficacy comparison among uveitis aetiologies. Ocul Immunol Inflamm. 2021;1–8. [ Epub ahead of print]. doi:10.1080/09273948.2020.1857791.
  • Gupta SR, Phan IT, Suhler EB. Successful treatment of refractory sympathetic ophthalmia in a child with infliximab. Arch Ophthalmol. 2011;129(2):250–252. doi:10.1001/archophthalmol.2010.358.
  • Menghini M, Frimmel SA, Windisch R, Meier FM. Efficacy of infliximab therapy in two patients with sympathetic ophthalmia. Klin Monbl Augenheilkd. 2011;228(4):362–363. doi:10.1055/s-0031-1273263.
  • Ramirez ED, Gujarro JJG, Vicuna RG. Postsurgical sympathetic ophthalmia refractory to treatment: the response to infliximab. Retin Cases Br Rep. 2012;6(2):169–171. doi:10.1097/ICB.0b013e3182235354.
  • Mesquida M, Molins B, Llorenc V, et al. Twenty-four month follow-up of tocilizumab therapy for refractory uveitis-related macular edema. Retina. 2018;38(7):1361–1370. doi:10.1097/IAE.0000000000001690.
  • Cunningham ET, Adán A, Nguyen QD, Zierhut M. Tocilizumab for the treatment of ocular inflammatory disease. Ocul Immunol Inflamm. 2021;29(1):2–5. doi:10.1080/09273948.2020.1859257.
  • Zhong Z, Su G, Kijlstra A, Yang P. Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis. Prog Retin Eye Res. 2020;May:100866. doi:10.1016/j.preteyeres.2020.100866.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.